Upon completion of the study, the company plans to submit the OTTAVA system for De Novo authorization in the U.S.

Johnson & Johnson MedTech (NYSE: JNJ) announced today that investigators completed the first cases with its Ottava surgical ...

Johnson & Johnson plans to seek a U.S. indication for multiple general surgery procedures, including gastric bypass, which ...

Johnson & Johnson MedTech reported that it has completed the first U.S. clinical cases of its Ottava surgical robot, with a ...

Upon completion of the study, the company plans to submit the OTTAVA system for De Novo authorization in the United States.

Intuitive Surgical leads in robotic surgery, but rising competition and high valuations urge caution. See why we are neutral ...

Johnson & Johnson’s Medtech division reported the completion of the first cases in the clinical trial for the Ottava robotic ...

Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, today announced completion of the first cases in the clinical trial for the OTTAVA™ Robotic Surgical System. The ...